Tagreed Alkaltham։ Blood Is a Naturally Integrated and Adaptive Physiological System
Tagreed Alkaltham, Transfusion Medicine Lab Supervisor at KSMC, shared a post on LinkedIn:
”Blood Is Not a Substance. It Is a System.
This is a reflective perspective on blood not simply as a component of therapy, but as a naturally integrated physiological system.
In medicine, innovation continues to expand the ways we support patients:
- Science advances.
- Therapies evolve.
- New approaches emerge to assist specific physiological needs.
Yet when we look at blood more closely, we recognize something deeper:
- Blood is not a single component.
- It is not merely hemoglobin.
- It is not only volume or clotting factors.
Blood is an integrated biological system:
- Red blood cells restore oxygen carrying capacity.
- Plasma maintains coagulation balance and protein regulation.
- Platelets respond instantly to vascular injury.
- Cryoprecipitate supports fibrin formation and structural clot stability.
Each component plays a distinct role but their true strength lies in coordination.
Beyond individual functions, human blood is biologically adaptive:
- It senses hypoxia.
- It adjusts oxygen release.
- It interacts with immune and coagulation pathways.
- It maintains equilibrium in a constantly changing internal environment.
This dynamic integration is what makes blood uniquely powerful.
Modern medicine offers many ways to support specific functions.
These advances are valuable and continue to improve patient care.
Yet human blood remains a naturally coordinated biological whole responsive, adaptive, and physiologically intelligent.
At its core, blood represents an orchestrated balance where structure, function, and response coexist.
Seen as a whole, blood is a naturally integrated physiological system responsive by design.”
Other posts featuring Tagreed Alkaltham on Hemostasis Today.
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026
-
Jul 12, 2026, 06:45Brian O Mahony: Advancing Concizumab Therapy for Hemophilia With Inhibitors at ISTH 2026
-
Jul 12, 2026, 06:42PERT-Guided Patient Selection for Advanced Pulmonary Embolism Therapies